Robert Schlaberg

2.6k total citations · 1 hit paper
45 papers, 1.3k citations indexed

About

Robert Schlaberg is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Robert Schlaberg has authored 45 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 14 papers in Infectious Diseases and 13 papers in Molecular Biology. Recurrent topics in Robert Schlaberg's work include Pneumonia and Respiratory Infections (7 papers), Cervical Cancer and HPV Research (6 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Robert Schlaberg is often cited by papers focused on Pneumonia and Respiratory Infections (7 papers), Cervical Cancer and HPV Research (6 papers) and Bacterial Identification and Susceptibility Testing (6 papers). Robert Schlaberg collaborates with scholars based in United States, Germany and Norway. Robert Schlaberg's co-authors include Steve Miller, Gary W. Procop, George M. Weinstock, Charles Y. Chiu, Keith E. Simmon, Mark Fisher, Keith D. Tardif, Richard C. Huard, Phyllis Della‐Latta and Karen Eilbeck and has published in prestigious journals such as PLoS ONE, Annals of Neurology and Journal of Virology.

In The Last Decade

Robert Schlaberg

44 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection

2017 371 citations Robert Schlaberg, Charles Y. Chiu et al. Archives of Pathology & Laboratory Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Schlaberg United States	18	661	353	315	219	180	45	1.3k
Joann L. Cloud United States	15	678 1.0×	316 0.9×	371 1.2×	132 0.6×	206 1.1×	23	1.2k
P. Riegel France	23	572 0.9×	259 0.7×	319 1.0×	160 0.7×	151 0.8×	40	1.4k
Robert Fader United States	19	419 0.6×	169 0.5×	343 1.1×	49 0.2×	92 0.5×	55	1.1k
Xiang Y. Han United States	32	1.6k 2.5×	383 1.1×	1.4k 4.5×	173 0.8×	397 2.2×	72	2.6k
Michael A. Saubolle United States	23	1.2k 1.8×	268 0.8×	952 3.0×	568 2.6×	559 3.1×	50	2.1k
Ami M. Y. Fung Hong Kong	21	533 0.8×	398 1.1×	436 1.4×	86 0.4×	27 0.1×	33	1.4k
P. Rocco LaSala United States	14	340 0.5×	159 0.5×	243 0.8×	65 0.3×	71 0.4×	34	835
Paul R. Georghiou Australia	13	250 0.4×	180 0.5×	134 0.4×	141 0.6×	119 0.7×	21	749
Simon Stubbs United Kingdom	16	705 1.1×	290 0.8×	1.0k 3.3×	185 0.8×	51 0.3×	22	1.5k
Béatrice Ninet Switzerland	21	990 1.5×	201 0.6×	572 1.8×	29 0.1×	72 0.4×	46	1.6k

Countries citing papers authored by Robert Schlaberg

Since Specialization

Citations

This map shows the geographic impact of Robert Schlaberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Schlaberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Schlaberg more than expected).

Fields of papers citing papers by Robert Schlaberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Schlaberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Schlaberg. The network helps show where Robert Schlaberg may publish in the future.

Co-authorship network of co-authors of Robert Schlaberg

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Schlaberg. A scholar is included among the top collaborators of Robert Schlaberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Schlaberg. Robert Schlaberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramchandar, Nanda, Jennifer Foley, Nidhi Shah, et al.. (2024). Pathogen kinetics and detection by next-generation sequencing in pediatric complicated pneumonia. Diagnostic Microbiology and Infectious Disease. 110(2). 116468–116468. 1 indexed citations

Azar, Marwan M., Robert Schlaberg, Maricar Malinis, et al.. (2020). Added Diagnostic Utility of Clinical Metagenomics for the Diagnosis of Pneumonia in Immunocompromised Adults. CHEST Journal. 159(4). 1356–1371. 16 indexed citations

Martin, Rebekah M., Dinesh Verma, Heng Xie, et al.. (2020). Contact Transmission of Vaccinia to an Infant Diagnosed by Viral Culture and Metagenomic Sequencing. Open Forum Infectious Diseases. 7(4). ofaa111–ofaa111. 5 indexed citations

Schwebke, Jane R., Stephanie N. Taylor, Ronald Ackerman, et al.. (2019). Clinical Validation of the Aptima Bacterial Vaginosis and Aptima Candida/Trichomonas Vaginitis Assays: Results from a Prospective Multicenter Clinical Study. Journal of Clinical Microbiology. 58(2). 38 indexed citations

Pyne, Michael T., Keith D. Tardif, Laurie Lesher, et al.. (2019). Clinical Performance of SurePath™ Preservative Compared to PreservCyt® with Cobas® and Hybrid Capture® 2 HPV Tests in a Colposcopy Population. Clinical Laboratory. 65(03/2019). 1 indexed citations

Schlaberg, Robert. (2019). Microbiome Diagnostics. Clinical Chemistry. 66(1). 68–76. 31 indexed citations

Christensen, Robert D., Christian C. Yost, Phillip V. Gordon, et al.. (2018). Reference intervals for stool calprotectin in preterm neonates and their utility for the diagnosis of necrotizing enterocolitis. Journal of Perinatology. 38(10). 1379–1385. 20 indexed citations

Górska, Anna, Silke Peter, Matthias Willmann, et al.. (2018). Dynamics of the human gut phageome during antibiotic treatment. Computational Biology and Chemistry. 74. 420–427. 10 indexed citations

Comstock, Jessica, et al.. (2018). Gestational Psittacosis Resulting in Neonatal Death Identified by Next-Generation RNA Sequencing of Postmortem, Formalin-Fixed Lung Tissue. Open Forum Infectious Diseases. 5(8). ofy172–ofy172. 8 indexed citations

10.

Schlaberg, Robert. (2018). Metagenomics for the diagnosis of exotic infections. International Journal of Infectious Diseases. 73. 58–58. 1 indexed citations

11.

Pyne, Michael T., et al.. (2017). Sequencing of the Hepatitis D Virus RNA WHO International Standard. Journal of Clinical Virology. 90. 52–56. 10 indexed citations

12.

Schlaberg, Robert, Charles Y. Chiu, Steve Miller, Gary W. Procop, & George M. Weinstock. (2017). Validation of Metagenomic Next-Generation Sequencing Tests for Universal Pathogen Detection. Archives of Pathology & Laboratory Medicine. 141(6). 776–786. 371 indexed citations breakdown →

13.

Christensen, Robert D., Christian C. Yost, D K Lambert, et al.. (2016). Elevated fecal calprotectin levels during necrotizing enterocolitis are associated with activated neutrophils extruding neutrophil extracellular traps. Journal of Perinatology. 36(10). 862–869. 40 indexed citations

14.

Tardif, Keith D., et al.. (2016). Cervical Cytology Specimen Stability in Surepath Preservative and Analytical Sensitivity for HPV Testing with the cobas and Hybrid Capture 2 Tests. PLoS ONE. 11(2). e0149611–e0149611. 4 indexed citations

15.

Pyne, Michael T., et al.. (2015). High-risk HPV detection and genotyping by APTIMA HPV using cervical samples. Journal of Virological Methods. 221. 95–99. 3 indexed citations

16.

Tardif, Keith D., et al.. (2014). Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2. Journal of Clinical Virology. 61(3). 382–386. 13 indexed citations

17.

Schlaberg, Robert, Keith E. Simmon, & Mark A. Fisher. (2012). A Systematic Approach for Discovering Novel, Clinically Relevant Bacteria. Emerging infectious diseases. 18(3). 422–430. 59 indexed citations

18.

Schlaberg, Robert, Michael J. Mitchell, Edward W. Taggart, & Rosemary C. She. (2011). Verification of Performance Specifications for a US Food and Drug Administration–Approved Molecular Microbiology Test: Clostridium difficile Cytotoxin B Using the Becton, Dickinson and Company GeneOhm Cdiff Assay. Archives of Pathology & Laboratory Medicine. 136(1). 20–25. 2 indexed citations

19.

Schlaberg, Robert, et al.. (2008). Chronic myeloid leukemia and HIV-infection. Leukemia & lymphoma. 49(6). 1155–1160. 12 indexed citations

20.

Walker, Michelle, Robert Schlaberg, Arthur P. Hays, Robert Bowser, & W. Ian Lipkin. (2001). Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Annals of Neurology. 49(2). 249–253. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact